ZAZIBONA is a collaborative medicines registration initiative in Southern Africa focusing on dossier assessments and good manufacturing practice (cGMP) inspections.
ZAZIBONA was founded in October 2013 by four countries Zambia, Zimbabwe, Botswana and Namibia with the support of WHO prequalification and the Southern Africa Regional Program on Access to Medicines (SARPAM).
List of participating countries that make up Zazibona.
The ZaZiBoNa initiative assesses and evaluates a wide range of products, including essential medicines and medications used in the treatment of priority diseases or conditions identified by the Southern African Development Community (SADC).
The eligible products encompass the following SADC priority diseases or conditions:
Products included in the list of United Nations Commission for Life-Saving Commodities for Women and Children Final UN Commission Report_14sept2012.pdf (unfpa.org) are also eligible.
11 – 15 November 2024
Read MoreView a list of our latest publications
The study aimed at analysing the regulatory systems for medical...
Read More
Introduction ZaZiBoNa, the work-sharing initiative in the Southern African Development...
Read More
Introduction: National medicines regulatory agencies are faced with challenges including...
Read More